A citation-based method for searching scientific literature

Frédéric Rieux-Laucat, Alain Fischer, Françoise Le Deist. Curr Opin Immunol 2003
Times Cited: 90







List of co-cited articles
571 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity.
F Rieux-Laucat, F Le Deist, C Hivroz, I A Roberts, K M Debatin, A Fischer, J P de Villartay. Science 1995
26

Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.
G H Fisher, F J Rosenberg, S E Straus, J K Dale, L A Middleton, A Y Lin, W Strober, M J Lenardo, J M Puck. Cell 1995
25

Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II.
J Wang, L Zheng, A Lobito, F K Chan, J Dale, M Sneller, X Yao, J M Puck, S E Straus, M J Lenardo. Cell 1999
472
23

Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency.
Hyung J Chun, Lixin Zheng, Manzoor Ahmad, Jin Wang, Christina K Speirs, Richard M Siegel, Janet K Dale, Jennifer Puck, Joie Davis, Craig G Hall,[...]. Nature 2002
501
22

Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.
J Wu, J Wilson, J He, L Xiang, P H Schur, J D Mountz. J Clin Invest 1996
347
21

Autoimmune lymphoproliferative syndrome with somatic Fas mutations.
Eliska Holzelova, Cédric Vonarbourg, Marie-Claude Stolzenberg, Peter D Arkwright, Françoise Selz, Anne-Marie Prieur, Stéphane Blanche, Jirina Bartunkova, Etienne Vilmer, Alain Fischer,[...]. N Engl J Med 2004
195
20

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.
R Watanabe-Fukunaga, C I Brannan, N G Copeland, N A Jenkins, S Nagata. Nature 1992
18

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.
S E Straus, E S Jaffe, J M Puck, J K Dale, K B Elkon, A Rösen-Wolff, A M Peters, M C Sneller, C W Hallahan, J Wang,[...]. Blood 2001
307
17

Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways.
F Rieux-Laucat, F Le Deist, A Fischer. Cell Death Differ 2003
149
17

Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.
C E Jackson, R E Fischer, A P Hsu, S M Anderson, Y Choi, J Wang, J K Dale, T A Fleisher, L A Middelton, M C Sneller,[...]. Am J Hum Genet 1999
162
16

Chronic lymphadenopathy simulating malignant lymphoma.
V C Canale, C H Smith. J Pediatr 1967
145
14

Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer.
U Ramenghi, S Bonissoni, G Migliaretti, S DeFranco, F Bottarel, C Gambaruto, D DiFranco, R Priori, F Conti, I Dianzani,[...]. Blood 2000
81
14

Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations.
F Rieux-Laucat, S Blachère, S Danielan, J P De Villartay, M Oleastro, E Solary, B Bader-Meunier, P Arkwright, C Pondaré, F Bernaudin,[...]. Blood 1999
117
13


Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome.
J J Bleesing, M R Brown, S E Straus, J K Dale, R M Siegel, M Johnson, M J Lenardo, J M Puck, T A Fleisher. Blood 2001
93
13

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.
T Takahashi, M Tanaka, C I Brannan, N A Jenkins, N G Copeland, T Suda, S Nagata. Cell 1994
13

A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.
M C Sneller, S E Straus, E S Jaffe, J S Jaffe, T A Fleisher, M Stetler-Stevenson, W Strober. J Clin Invest 1992
232
12

Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment.
M Lenardo, K M Chan, F Hornung, H McFarland, R Siegel, J Wang, L Zheng. Annu Rev Immunol 1999
783
11

Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations.
R M Siegel, J K Frederiksen, D A Zacharias, F K Chan, M Johnson, D Lynch, R Y Tsien, M J Lenardo. Science 2000
500
11

Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
M C Sneller, J Wang, J K Dale, W Strober, L A Middelton, Y Choi, T A Fleisher, M S Lim, E S Jaffe, J M Puck,[...]. Blood 1997
269
11

The Fas death factor.
S Nagata, P Golstein. Science 1995
11

Autoimmune lymphoproliferative syndrome.
Michael C Sneller, Janet K Dale, Stephen E Straus. Curr Opin Rheumatol 2003
63
15

A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome.
Manuel Del-Rey, Jesus Ruiz-Contreras, Alberto Bosque, Sara Calleja, Jose Gomez-Rial, Ernesto Roldan, Pablo Morales, Antonio Serrano, Alberto Anel, Estela Paz-Artal,[...]. Blood 2006
79
12

Clinical, immunological, and pathological consequences of Fas-deficient conditions.
F Le Deist, J F Emile, F Rieux-Laucat, M Benkerrou, I Roberts, N Brousse, A Fischer. Lancet 1996
152
10

Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis.
A Bettinardi, D Brugnoni, E Quiròs-Roldan, A Malagoli, S La Grutta, A Correra, L D Notarangelo. Blood 1997
157
10

An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome.
S E Straus, M Sneller, M J Lenardo, J M Puck, W Strober. Ann Intern Med 1999
230
10

Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.
Joao B Oliveira, Jack J Bleesing, Umberto Dianzani, Thomas A Fleisher, Elaine S Jaffe, Michael J Lenardo, Frederic Rieux-Laucat, Richard M Siegel, Helen C Su, David T Teachey,[...]. Blood 2010
261
10


The CD95(APO-1/Fas) DISC and beyond.
M E Peter, P H Krammer. Cell Death Differ 2003
805
8

Fas and Fas ligand: lpr and gld mutations.
S Nagata, T Suda. Immunol Today 1995
809
8


The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations.
A K Vaishnaw, J R Orlinick, J L Chu, P H Krammer, M V Chao, K B Elkon. J Clin Invest 1999
124
7

Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder.
Y Kasahara, T Wada, Y Niida, A Yachie, H Seki, Y Ishida, T Sakai, F Koizumi, S Koizumi, T Miyawaki,[...]. Int Immunol 1998
72
9

The role of CD95 in the regulation of peripheral T-cell apoptosis.
Andreas Krueger, Stefanie C Fas, Sven Baumann, Peter H Krammer. Immunol Rev 2003
150
7

Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor.
F C Kischkel, S Hellbardt, I Behrmann, M Germer, M Pawlita, P H Krammer, M E Peter. EMBO J 1995
7

Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation.
U Dianzani, M Bragardo, D DiFranco, C Alliaudi, P Scagni, D Buonfiglio, V Redoglia, S Bonissoni, A Correra, I Dianzani,[...]. Blood 1997
130
7

The biochemistry of apoptosis.
M O Hengartner. Nature 2000
7


Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression.
U Lopatin, X Yao, R K Williams, J J Bleesing, J K Dale, D Wong, J Teruya-Feldstein, S Fritz, M R Morrow, I Fuss,[...]. Blood 2001
74
9

A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling.
F K Chan, H J Chun, L Zheng, R M Siegel, K L Bui, M J Lenardo. Science 2000
612
6

Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: a dominant or recessive disease?
M van der Burg, R de Groot, W M Comans-Bitter, J C den Hollander, H Hooijkaas, H J Neijens, R M Berger, A P Oranje, A W Langerak, J J van Dongen. Pediatr Res 2000
41
14


Perforin gene defects in familial hemophagocytic lymphohistiocytosis.
S E Stepp, R Dufourcq-Lagelouse, F Le Deist, S Bhawan, S Certain, P A Mathew, J I Henter, M Bennett, A Fischer, G de Saint Basile,[...]. Science 1999
859
6

Activation-induced cell death in T cells.
Douglas R Green, Nathalie Droin, Michael Pinkoski. Immunol Rev 2003
438
6

Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade.
P Li, D Nijhawan, I Budihardjo, S M Srinivasula, M Ahmad, E S Alnemri, X Wang. Cell 1997
6

The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity.
R M Siegel, F K Chan, H J Chun, M J Lenardo. Nat Immunol 2000
318
6

The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis.
A J Infante, H A Britton, T DeNapoli, L A Middelton, M J Lenardo, C E Jackson, J Wang, T Fleisher, S E Straus, J M Puck. J Pediatr 1998
88
6


Death receptors: signaling and modulation.
A Ashkenazi, V M Dixit. Science 1998
6

Role of inherited defects decreasing Fas function in autoimmunity.
Umberto Dianzani, Annalisa Chiocchetti, Ugo Ramenghi. Life Sci 2003
40
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.